Camellia PLC
LSE:CAM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Camellia PLC
LSE:CAM
|
UK |
|
Tilaknagar Industries Ltd
NSE:TI
|
IN |
|
Innovent Biologics Inc
HKEX:1801
|
CN |
|
K
|
Kitakei Co Ltd
TSE:9872
|
JP |
Balance Sheet
Balance Sheet Decomposition
Camellia PLC
Camellia PLC
Balance Sheet
Camellia PLC
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
165
|
155
|
163
|
156
|
171
|
211
|
232
|
270
|
209
|
262
|
216
|
205
|
299
|
191
|
81
|
42
|
108
|
112
|
91
|
99
|
62
|
49
|
48
|
99
|
|
| Cash |
165
|
155
|
163
|
156
|
171
|
211
|
204
|
255
|
157
|
217
|
197
|
181
|
219
|
191
|
0
|
0
|
43
|
41
|
31
|
58
|
26
|
20
|
18
|
31
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
28
|
15
|
51
|
45
|
19
|
24
|
81
|
0
|
81
|
42
|
65
|
71
|
60
|
41
|
36
|
29
|
30
|
68
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
12
|
34
|
35
|
51
|
61
|
36
|
0
|
159
|
31
|
0
|
0
|
0
|
0
|
4
|
1
|
1
|
0
|
|
| Total Receivables |
52
|
54
|
45
|
51
|
49
|
51
|
66
|
73
|
52
|
53
|
57
|
67
|
49
|
0
|
49
|
36
|
39
|
41
|
37
|
39
|
38
|
54
|
32
|
26
|
|
| Accounts Receivables |
42
|
45
|
36
|
43
|
41
|
44
|
57
|
65
|
45
|
46
|
50
|
59
|
40
|
0
|
40
|
28
|
30
|
35
|
30
|
31
|
33
|
29
|
26
|
21
|
|
| Other Receivables |
10
|
9
|
9
|
8
|
8
|
6
|
9
|
8
|
7
|
8
|
8
|
8
|
9
|
0
|
9
|
9
|
8
|
7
|
7
|
7
|
5
|
25
|
5
|
5
|
|
| Inventory |
34
|
32
|
25
|
25
|
18
|
19
|
20
|
31
|
28
|
35
|
39
|
38
|
44
|
0
|
44
|
58
|
54
|
62
|
58
|
55
|
60
|
71
|
58
|
55
|
|
| Other Current Assets |
3
|
3
|
3
|
14
|
5
|
4
|
4
|
5
|
4
|
14
|
6
|
6
|
8
|
0
|
8
|
272
|
11
|
8
|
8
|
7
|
18
|
19
|
100
|
59
|
|
| Total Current Assets |
254
|
243
|
235
|
245
|
243
|
284
|
325
|
390
|
326
|
399
|
370
|
377
|
340
|
0
|
340
|
439
|
212
|
224
|
195
|
199
|
181
|
195
|
239
|
239
|
|
| PP&E Net |
173
|
166
|
156
|
136
|
169
|
152
|
157
|
200
|
187
|
210
|
213
|
213
|
216
|
0
|
216
|
246
|
229
|
241
|
256
|
228
|
244
|
225
|
176
|
174
|
|
| PP&E Gross |
173
|
166
|
156
|
136
|
169
|
152
|
157
|
200
|
187
|
210
|
213
|
213
|
216
|
0
|
216
|
246
|
229
|
241
|
256
|
228
|
244
|
225
|
176
|
174
|
|
| Accumulated Depreciation |
80
|
84
|
91
|
96
|
83
|
80
|
83
|
98
|
98
|
104
|
104
|
104
|
120
|
0
|
120
|
142
|
143
|
154
|
162
|
167
|
167
|
142
|
137
|
131
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
1
|
6
|
6
|
6
|
6
|
5
|
5
|
4
|
5
|
0
|
5
|
2
|
4
|
11
|
9
|
6
|
6
|
5
|
4
|
4
|
|
| Goodwill |
3
|
2
|
2
|
2
|
4
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
0
|
4
|
0
|
0
|
0
|
1
|
1
|
5
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
20
|
18
|
14
|
15
|
23
|
0
|
0
|
2
|
2
|
3
|
3
|
2
|
3
|
3
|
3
|
2
|
|
| Long-Term Investments |
72
|
79
|
84
|
83
|
128
|
119
|
132
|
144
|
128
|
64
|
75
|
66
|
132
|
0
|
132
|
124
|
129
|
133
|
141
|
147
|
141
|
142
|
78
|
56
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
4
|
5
|
7
|
3
|
3
|
1
|
1
|
1
|
3
|
0
|
3
|
0
|
1
|
0
|
1
|
0
|
15
|
1
|
0
|
0
|
|
| Other Assets |
3
|
2
|
2
|
2
|
4
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
0
|
4
|
0
|
0
|
0
|
1
|
1
|
5
|
1
|
1
|
1
|
|
| Total Assets |
496
N/A
|
486
-2%
|
473
-3%
|
463
-2%
|
549
+19%
|
569
+4%
|
631
+11%
|
748
+19%
|
673
-10%
|
701
+4%
|
680
-3%
|
680
0%
|
722
+6%
|
0
N/A
|
722
N/A
|
814
+13%
|
577
-29%
|
610
+6%
|
606
-1%
|
582
-4%
|
594
+2%
|
572
-4%
|
500
-13%
|
476
-5%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
164
|
163
|
153
|
154
|
189
|
223
|
264
|
299
|
238
|
241
|
216
|
216
|
231
|
0
|
231
|
30
|
28
|
25
|
21
|
22
|
18
|
22
|
22
|
19
|
|
| Accrued Liabilities |
13
|
8
|
8
|
8
|
7
|
7
|
7
|
7
|
6
|
7
|
6
|
7
|
9
|
0
|
9
|
10
|
11
|
12
|
8
|
9
|
15
|
12
|
11
|
8
|
|
| Short-Term Debt |
27
|
31
|
28
|
28
|
21
|
13
|
11
|
15
|
8
|
5
|
7
|
0
|
5
|
0
|
5
|
1
|
1
|
3
|
2
|
4
|
2
|
4
|
14
|
15
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
0
|
4
|
4
|
4
|
5
|
1
|
0
|
6
|
1
|
0
|
1
|
1
|
1
|
1
|
5
|
3
|
5
|
4
|
7
|
1
|
|
| Other Current Liabilities |
8
|
9
|
9
|
14
|
7
|
8
|
8
|
16
|
16
|
22
|
19
|
19
|
30
|
0
|
30
|
279
|
43
|
44
|
34
|
50
|
44
|
44
|
33
|
38
|
|
| Total Current Liabilities |
213
|
211
|
199
|
204
|
225
|
254
|
293
|
340
|
273
|
275
|
248
|
248
|
275
|
0
|
275
|
321
|
84
|
84
|
69
|
88
|
84
|
86
|
86
|
81
|
|
| Long-Term Debt |
37
|
36
|
26
|
21
|
11
|
15
|
12
|
11
|
3
|
0
|
0
|
0
|
5
|
0
|
5
|
5
|
4
|
3
|
15
|
13
|
26
|
24
|
12
|
11
|
|
| Deferred Income Tax |
2
|
7
|
4
|
4
|
27
|
25
|
27
|
33
|
30
|
35
|
35
|
36
|
40
|
0
|
40
|
43
|
40
|
46
|
47
|
40
|
38
|
37
|
28
|
28
|
|
| Minority Interest |
63
|
60
|
56
|
50
|
21
|
19
|
21
|
30
|
33
|
38
|
40
|
40
|
40
|
0
|
40
|
49
|
50
|
57
|
57
|
49
|
49
|
49
|
38
|
39
|
|
| Other Liabilities |
3
|
2
|
2
|
2
|
23
|
20
|
12
|
29
|
40
|
23
|
35
|
43
|
42
|
0
|
42
|
66
|
31
|
24
|
22
|
16
|
9
|
8
|
10
|
9
|
|
| Total Liabilities |
317
N/A
|
316
0%
|
287
-9%
|
281
-2%
|
307
+9%
|
333
+8%
|
364
+9%
|
444
+22%
|
379
-15%
|
371
-2%
|
359
-3%
|
366
+2%
|
401
+10%
|
0
N/A
|
401
N/A
|
483
+20%
|
208
-57%
|
215
+3%
|
210
-2%
|
206
-2%
|
205
0%
|
203
-1%
|
174
-14%
|
168
-4%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
140
|
132
|
151
|
147
|
227
|
221
|
251
|
289
|
279
|
314
|
306
|
299
|
306
|
0
|
306
|
316
|
353
|
380
|
381
|
361
|
373
|
354
|
311
|
293
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
0
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
15
|
|
| Unrealized Security Profit/Loss |
38
|
37
|
35
|
34
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
179
N/A
|
170
-5%
|
187
+9%
|
182
-2%
|
242
+33%
|
236
-2%
|
266
+13%
|
304
+14%
|
294
-3%
|
330
+12%
|
322
-2%
|
314
-2%
|
321
+2%
|
0
N/A
|
321
N/A
|
331
+3%
|
368
+11%
|
396
+7%
|
396
+0%
|
377
-5%
|
389
+3%
|
369
-5%
|
326
-12%
|
309
-5%
|
|
| Total Liabilities & Equity |
496
N/A
|
486
-2%
|
473
-3%
|
463
-2%
|
549
+19%
|
569
+4%
|
631
+11%
|
748
+19%
|
673
-10%
|
701
+4%
|
680
-3%
|
680
0%
|
722
+6%
|
0
N/A
|
722
N/A
|
814
+13%
|
577
-29%
|
610
+6%
|
606
-1%
|
582
-4%
|
594
+2%
|
572
-4%
|
500
-13%
|
476
-5%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|